Cargando…
The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
We have investigated to develop novel vaccines against SARS CoV using cDNA constructs encoding the structural antigen; spike protein (S), membrane protein (M), envelope protein (E), or nucleocapsid (N) protein, derived from SARS CoV. Mice vaccinated with SARS-N or -M DNA using pcDNA 3.1(+) plasmid v...
Autores principales: | Okada, Masaji, Takemoto, Yuji, Okuno, Yoshinobu, Hashimoto, Satomi, Yoshida, Shigeto, Fukunaga, Yukari, Tanaka, Takao, Kita, Yoko, Kuwayama, Sachiko, Muraki, Yumiko, Kanamaru, Noriko, Takai, Hiroko, Okada, Chika, Sakaguchi, Yayoi, Furukawa, Izumi, Yamada, Kyoko, Matsumoto, Makoto, Kase, Tetsuo, deMello, Daphne E., Peiris, J.S.M., Chen, Pei-Jer, Yamamoto, Naoki, Yoshinaka, Yoshiyuki, Nomura, Tatsuji, Ishida, Isao, Morikawa, Shigeru, Tashiro, Masato, Sakatani, Mitsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115605/ https://www.ncbi.nlm.nih.gov/pubmed/15755609 http://dx.doi.org/10.1016/j.vaccine.2005.01.036 |
Ejemplares similares
-
Development of Vaccines and Passive Immunotherapy Against Sars Coronavirus Using Mouse and Scid-PBL/hu Mouse Models
por: Okada, Masaji, et al.
Publicado: (2006) -
Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
por: Okada, Masaji, et al.
Publicado: (2007) -
Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras
Publicado: (1994) -
Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice
por: Santini, Stefano M., et al.
Publicado: (2000) -
Complete prevention of HTLV-1 infection in humanized mice (hu-PBL SCID) by a neutralizing monoclonal antibody to envelope gp46
por: Saito, Mineki, et al.
Publicado: (2014)